About 40 million people worldwide suffer from bipolar disorder, according to the World Health Organization
Thermo Fisher's test to detect pregnancy-related complication gets FDA nod
The condition happens in about 1 in 25 pregnancies in the United States
Published : 20 May 2023, 05:52 AM
Updated : 20 May 2023, 05:59 AM
The US Food and Drug Administration (FDA) has cleared Thermo Fisher Scientific Inc's test, the first of its kind in the country, to detect women with risk of severe preeclampsia, the company said on Friday.
Preeclampsia is a leading cause of mortality in pregnant women globally, where they could experience high blood pressure after 20 weeks of pregnancy and during the postpartum period.
The condition happens in about 1 in 25 pregnancies in the United States, according to the US Centers for Disease Control and Prevention.
The FDA clearance is based on a study that examined data from over 700 pregnant women in 18 US hospitals.
The regulatory nod for the biomarker test will have a significant impact on prognosis and treatment for thousands of women at risk for preeclampsia every year in the US, said Alan Sachs, chief medical officer at Thermo Fisher Scientific.
RELATED STORIES
Baltimore's shipping channel has been blocked since a fully loaded container ship lost power and collided with a support column of the Francis Scott Key Bridge last Tuesday
The steel truss bridge collapsed early on Tuesday morning, killing six road workers, when a massive container ship lost power and crashed into a support pylon
The six victims of the Francis Scott Key Bridge collapse were all immigrants from Mexico and Central America, doing the kind of grueling work that many immigrants take on
